Search

Author/Creator Manger, B

1. Assessing the intra- and inter-reader reliability of dynamic ultrasound images in power Doppler ultrasonography. Issue 12 (25th May 2006)

Authors:
Koski, J M; Saarakkala, S; Helle, M; Hakulinen, U; Heikkinen, J O; Hermunen, H; Balint, P; Bruyn, G A; Filippucci, E; Grassi, W; Iagnocco, A; Luosujärvi, R; Manger, B; De Miguel, E; Naredo, E; Scheel, A K; Schmidt, W A; Soini, I; Szkudlarek, M; Terslev, L
Journal:
Annals of the rheumatic diseases
Issue:
Volume 65:Issue 12(2006)
Page Start:
1658
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus. Issue 12 (1st December 2002)

Authors:
Manger, K; Manger, B; Repp, R; Geisselbrecht, M; Geiger, A; Pfahlberg, A; Harrer, T; Kalden, J R
Journal:
Annals of the rheumatic diseases
Issue:
Volume 61:Issue 12(2002)
Page Start:
1065
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions. Issue 2 (7th October 2009)

Authors:
Van den Bosch, F; Manger, B; Goupille, P; McHugh, N; Rødevand, E; Holck, P; van Vollenhoven, R F; Leirisalo-Repo, M; FitzGerald, O; Kron, M; Frank, M; Kary, S; Kupper, H
Journal:
Annals of the rheumatic diseases
Issue:
Volume 69:Issue 2(2010)
Page Start:
394
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. FRI0071 Responses to infliximab therapy in the attract trial assess with the disease activity score (das): clinical response measured by das at 102 weeks correlates with arrest of radiologic progression and shows higher response rate than acr20 criteria. (1st June 2001)

Authors:
Antoni, CE; Kavanaugh, A; Manger, B; Keenan, G; Schaible, T; Harriman, G; Patel, K; Kalden, J
Journal:
Annals of the rheumatic diseases
Issue:
Volume 60(2001)Supplement 1
Page Start:
A474
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. FRI0098 Elevated multi-biomarker disease activity (MBDA) predicts relapses in ra patients in sustained remission tapering tumour necrosis factor inhibitor therapy- results from the randomized controlled retro study. (15th June 2017)

Authors:
Rech, J; Hagen, M; Englbrecht, M; Haschka, J; Reiser, M; Kleyer, A; Hueber, A; Manger, B; Figuereido, C; Cobra, J Fogagnolo; Tony, H-P; Finzel, S; Kleinert, S; Wendler, J; Schuch, F; Ronneberger, M; Feuchtenberger, M; Fleck, M; Manger, K; Ochs, W
Journal:
Annals of the rheumatic diseases
Issue:
Volume 76(2017)Supplement 2
Page Start:
516
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗